Potenza Therapeutics

About:

Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs.

Website: http://potenzatherapeutics.com/

Twitter/X: potenzatx

Top Investors: MPM Capital, InterWest Partners

Description:

Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity. It was founded in 2014 and headquartered in Cambridge, Massachusetts.

Total Funding Amount:

$35M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)potenzatx.com

Founders:

Dan Hicklin, Drew Pardoll

Number of Employees:

11-50

Last Funding Date:

2017-12-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai